The largest database of trusted experimental protocols
> Disorders > Sign or Symptom > Excessive Daytime Sleepiness

Excessive Daytime Sleepiness

Excessive Daytime Sleepiness is a condition characterized by persistent drowsiness and an inability to stay awake during the day, despite adequate nighttime sleep.
It can be caused by a variety of underlying medical conditions, such as sleep apnea, narcolepsy, or chronic fatigue syndrome.
PubCompare.ai's AI-powered research protocols can help researchers improve the reproducibility and accuracy of studies on Excessive Daytime Sleepiness, allowing them to easily locate and compare protocols from literature, pre-prints, and patents to find the best solutions for their research needs.
Experence the power of AI-driven comparisons today and discover new insights into this complex sleep disorder.

Most cited protocols related to «Excessive Daytime Sleepiness»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2011
Adult Diagnosis Excessive Daytime Sleepiness Health Personnel Hypersomnolence, Idiopathic Movement Narcolepsy Patients Pharmaceutical Preparations Polysomnography Restless Legs Syndrome Sleep Sleep Apnea, Obstructive Sleep Apnea Syndromes Sleep Disorders Sleeplessness Snoring Somnolence

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2021
Chronotype Excessive Daytime Sleepiness Friend N-(4-aminophenethyl)spiroperidol Sleep Sleeplessness

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2020
Actigraphy Cardiovascular System Cholesterol Chronotype Congenital Abnormality Depressive Symptoms Diabetes Mellitus Ethnicity Excessive Daytime Sleepiness High Density Lipoprotein Cholesterol Hypersensitivity Polysomnography Sleep Sleep Apnea Syndromes Sleeplessness Systolic Pressure
The same sample size and inclusion criteria were used in three previous studies from our group [9 , 19 (link), 20 (link)]: 15–19 years of age, no known health conditions, no sleep disorders, body mass index (BMI) of 30 kg/m2 or less, not a habitual short sleeper (actigraphically measured TIB <6 h averaged across weekdays and weekends, with weekend sleep extension ≤1 h), consumption of 5 cups of caffeinated beverages or less a day, and no travel across more than two time zones 1 month prior to the experiment.
A total of 126 adolescents were assessed for eligibility for this 15-day parallel-group study. Of these, 60 (30 males) were randomly assigned to the split sleep group (n = 30) and the continuous sleep group (n = 30). Two participants dropped out, and analyses were based on 58 participants (Supplementary Figure S1). Although the primary goal of the current work was to compare two sleep restriction schedules, the data generated were also appraised in light of the recommended sleep duration for adolescents (8–10 hours per night). To this end, we compared the present findings to previously published data on students sleeping 9-hour TIB at night [19 (link)], recruited using the recruitment criteria used in the present study.
The three groups were similar in multiple measures assessed during screening, including age, sex, and BMI percentile (based on the Singaporean BMI-for-age growth charts), as well as daily caffeine consumption, morningness–eveningness preference [21 (link)], excessive daytime sleepiness [22 (link)], and symptoms of chronic sleep reduction [23 (link)] (p > 0.10; Table 1). Although the split and the continuous sleep groups did not differ in sleep behavior based on both self-report [24 (link)] and actigraphy (Table 1), some slight differences were found with the control group from our previous protocol 3 years ago. Specifically, the control group seemed to sleep less on weekdays, but extended their sleep more on weekends. Thus, critically, actigraphically assessed total sleep time (TST) averaged across the week was comparable across all three groups (p > 0.66). Overall, based on actigraphy data, the three groups spent about 6.1–7.0 hours per night in bed on school nights, with more than an hour of sleep extension on weekends. This was far less than the recommended sleep duration of 8–10 hours for adolescents [1 (link), 2 (link)]. Self-reported nap duration, which was not assessed in the control group, averaged 1 hour in both split sleep and the continuous sleep groups (Table 1, p = 0.75).
During the week prior to the experiment, napping was not allowed and a 9-hour nocturnal sleep schedule (23:00–08:00) was enforced for minimizing the effects of prior sleep loss and for facilitating stable circadian entrainment. The split and the continuous sleep groups did not differ in actigraphically assessed TIB (mean ± SEM for continuous sleep: 8.99 ± 0.06 hours vs. split sleep: 9.07 ± 0.08 hours, p = 0.43) or TST (7.37 ± 0.08 hours vs. 7.44 ± 0.10 hours, p = 0.62).
Publication 2019
Actigraphy Adolescent Beverages Caffeine Chronotype Eligibility Determination Excessive Daytime Sleepiness Index, Body Mass Light Males Sleep Sleep Disorders Student
This prospective cross-sectional study was approved by Universidade Federal do Espírito
Santo Institutional Review Board under protocol #162/09. All participants signed an
informed consent form before data collection. All procedures were performed by trained
and calibrated researchers.
The study was carried out with two distinct populations: orthodontists and children. A
sample of 110 orthodontists answered a semi-structured questionnaire about clinical
evaluation of respiratory patterns during childhood and their knowledge about SDB in
children. Data collection was tabulated and analyzed. Lack of standardization of the
procedures employed by orthodontists as well as of diagnostic information in the
literature led us to prepare basic guidelines to clinically recognize MB in children
(Table 1), based on the most cited
procedures.
Proposed guidelines for clinical recognition of mouth breathing
CLINICAL RECOGNITION OF MOUTH BREATHING
These guidelines can be used to examine children
and aid recognition of mouth breathing
1. Visual assessment
The dentist should assess at least the presence
of the following characteristics:
With the patient standing:
» Lack of lip seal( ) YES ( ) NO
» Posture changes( ) YES ( ) NO
» Dark eye circles( ) YES ( ) NO
» Long face( ) YES ( ) NO
With the patient sited:
» Anterior open bite ( ) YES ( ) NO
» High narrow palate( ) YES ( ) NO
» Gingivitis in maxillary incisors( ) YES ( ) NO
2. Questions
Questions should be directed to the child or
parents
Do you:
» Sleep with your mouth open?( ) YES ( ) NO
» Keep your mouth open when you are
distracted?
( ) YES ( ) NO
» Snore?( ) YES ( ) NO
» Drool on your pillow?( ) YES ( ) NO
» Experience excessive daytime sleepiness?( ) YES ( ) NO
» Wake up with a headache?( ) YES ( ) NO
» Get tired easily?( ) YES ( ) NO
» Often have allergies?( ) YES ( ) NO
» Often have a stuffy nose and/or runny
nose?
( ) YES ( ) NO
» Have difficulty in school?( ) YES ( ) NO
» Have difficulty concentrating?( ) YES ( ) NO
3. Breathing tests
The child must be sitting. At least two tests
should be performed.
a. Graded mirror test
After the second output of air on the mirror,
mark the halo area with a marker (Fig 1).
(Low nasal flow: up to 30 mm; Average nasal
flow: 30-60 mm; High nasal flow: above 60 mm)
b. Water retention test
Place water in the patient’s mouth
(approximately 15 ml) and ask him/her to hold it for 3 minutes.
c. Lip seal test
Seal the patient’s mouth completely with a tape
for 3 minutes.
4. Training to eliminate the habit of mouth breathing
Training should be performed at home on a daily
basis until the child is able to return to nasal breathing.
Lip seal test
Seal the child’s mouth with masking tape when
he/she is distracted or focusing his/her attention on another activity.
Progressively increase the time each day until the child is able to
breathe only through the nose for, at least, two consecutive hours.
Guidelines presented in Table 1 were applied to
687 children aged 6-12 years old and attending elementary schools. Only healthy children
whose parents gave permission to participate were included.
Children were clinically assessed and received diagnostic impressions as mouth breathers
or nose breathers according to their clinical characteristics. Subsequently, they were
subjected to three breathing tests selected to assist MB recognition: the mirror test,
the water retention test and the lip seal test. All tests were performed with the child
sitting with his/her head straight, keeping his/her lips closed, and breathing
normally.
Full text: Click here
Publication 2015
Attention Breath Tests Child Dentist Diagnosis Ethics Committees, Research Excessive Daytime Sleepiness Face Gingivitis Head Headache Hypersensitivity Incisor Lip Maxilla Nose Open Bite Oral Cavity Orthodontist Palate Parent Patients Phocidae Population Group Respiratory Rate Retention (Psychology) Sleep Snoring

Most recents protocols related to «Excessive Daytime Sleepiness»

(1) Clinical efficacy: Cure: the hiccup completely stopped 3 days after treatment. Remission: the attack times of hiccup were obviously reduced, which is more than 50% lower than that before treatment. Invalid: the above criteria are not met or the disease aggravates [12 (link)]. Total effective rate = (cured + relieved) cases/total cases × 100%. The patient’s median response time, the median cure time, and the one-time medication response rate were recorded. (2) Adverse reactions and recurrence: adverse reactions including fatigue (conscious fatigue and limb weakness), drowsiness (excessive daytime sleep or sleep onset), tremors (rhythmic and alternating swinging movements), and hiccup recurrence after drug discontinuation were recorded during the treatment.
Full text: Click here
Publication 2023
Aftercare Asthenia Consciousness Excessive Daytime Sleepiness Fatigue Movement Patients Pharmaceutical Preparations Recurrence Sleep Somnolence Tremor
Bilevel PAP data was downloaded from the device at 3 and 12 months. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI) where a score of ≥5 indicates impaired sleep quality and the minimal clinically important difference (MCID) has been defined as ranging from 1.5 to 3 (22 (link),23 (link)). Subjective daytime sleepiness was assessed using the Epworth Sleepiness Scale (ESS), where a score of >10 indicates excessive daytime sleepiness and the MCID ranges from 2 to 3 (24 (link)). Fatigue was assessed using the Pichot Fatigue Scale, where a score >22 indicates excessive fatigue. Questionnaires were administered and scale scores were determined at baseline prior to initiation of bilevel PAP when patients were still being treated with CPAP/APAP, and then at sleep center visits after 3 and 12 months. The presence or absence of therapy-related side effects was determined by patient interview at each follow-up visit. The presence/severity of side effects was rated on a visual analogue scale from 0 (not at all) to 10 (very important). Patient satisfaction with bilevel PAP was determined based on direct questioning, and asking the question “Do you want to continue treatment?”.
Publication 2023
Acetaminophen Continuous Positive Airway Pressure Excessive Daytime Sleepiness Fatigue Medical Devices Patients Sleep Somnolence Visual Analog Pain Scale
The ESS consists of eight questions with a four-point Likert response scale (0-3) and a score range of 0-24. A score of 10 on the ESS suggests a high risk of OSA and excessive daytime sleepiness (8 (link)). A total of eight yes/no items comprise the STOP-BANG questionnaire, four of which are demographic (BANG: BMI, >35 kg/m2; age, >50 years; neck circumference, >40 cm; male sex) and four of which are subjective (STOP: snoring, fatigue, observed apnea and elevated blood pressure). The overall score is between 0 and 8. The patient is at a high risk for OSA if they respond ‘yes’ to three or more questions (9 (link)). The 11 questions of the Berlin questionnaire are divided into three groups: Five questions concerning snoring are included in the first category, three questions about daytime sleepiness and fatigue are included in the second category, and information about BMI and the history of hypertension is included in the third and final category. The answers to these three categories were used to calculate the Berlin questionnaire score as follows: The first and second categories were deemed positive if the answers suggested frequent symptoms (>3-4 times/week) on two or more survey items, and the third category was determined as positive if there was a history of arterial hypertension or a BMI of >30 kg/m2. The participants were categorized as being at a high risk of having OSA if they scored positively in two or more categories (10 (link)). Valid Greek language versions of the aforementioned questionnaires were used (12-14 (link)).
The NoSAS score was first translated into Greek by a professional translation company. The translated score was then translated back into English by clinicians who were proficient in the language. The clinicians determined on the final version of the translated score. A NoSAS score ≥8 is suggestive of being at high risk for OSA (11 (link)).
Publication 2023
Apnea Blood Pressure Excessive Daytime Sleepiness Fatigue High Blood Pressures Males Neck Patients
A detailed medical history regarding the presence of chronic respiratory symptoms, sleep habits, comorbidities, current medication, and smoking status was obtained. In addition, anthropometric characteristics, namely, height, weight, body mass index, and neck, waist and hip circumference, were recorded at initial evaluation.
Daytime sleepiness was assessed with the Greek version of the Epworth Sleepiness Scale (ESS).14 ESS evaluates the probability of falling asleep in a variety of daily circumstances; the maximum total score is 24, and scores above 10 are considered indicative of excessive daytime sleepiness.
Full text: Click here
Publication 2023
Excessive Daytime Sleepiness Index, Body Mass Neck Pharmaceutical Preparations Signs and Symptoms, Respiratory Somnolence
Clinical care for all patients was offered at the discretion of the attending clinician based on current guidelines [24 (link), 25 (link)]. When clinically indicated, PCI with stenting or coronary artery bypass graft (CABG) was performed. Patients with OSA, particularly those with excessive daytime sleepiness, were referred to sleep centers for further evaluation and treatment.
Full text: Click here
Publication 2023
Coronary Artery Bypass Surgery Excessive Daytime Sleepiness Patients Sleep

Top products related to «Excessive Daytime Sleepiness»

Sourced in United States, Australia
The Alice 6 is a lab equipment product designed for sleep analysis. It is a diagnostic device that records various physiological signals during sleep to help healthcare professionals assess sleep patterns and disorders.
Sourced in United States
The Alice 4 or 5 is a laboratory equipment product manufactured by Philips. It is designed to perform core functions essential for laboratory operations. The device's detailed specifications and intended use are not available for this response.
Sourced in United States, Germany
The Radical-7 is a versatile patient monitoring system designed for use in healthcare settings. It provides continuous, noninvasive measurement of oxygen saturation, pulse rate, and other vital signs. The Radical-7 utilizes Masimo's trusted signal processing technology to deliver accurate and reliable data, enabling healthcare professionals to make informed decisions about patient care.
Sourced in United States, Denmark, United Kingdom, Belgium, Japan, Austria, China
Stata 14 is a comprehensive statistical software package that provides a wide range of data analysis and management tools. It is designed to help users organize, analyze, and visualize data effectively. Stata 14 offers a user-friendly interface, advanced statistical methods, and powerful programming capabilities.
Sourced in United States, Denmark, Austria, United Kingdom, Japan, Canada
Stata version 14 is a software package for data analysis, statistical modeling, and graphics. It provides a comprehensive set of tools for data management, analysis, and reporting. Stata version 14 includes a wide range of statistical techniques, including linear regression, logistic regression, time series analysis, and more. The software is designed to be user-friendly and offers a variety of data visualization options.
Sourced in United States, Japan, United Kingdom
SPSS for Windows version 22.0 is a statistical software package designed to analyze and manage data. It provides a range of tools for data manipulation, statistical analysis, and visualization. The software is compatible with the Windows operating system.
Sourced in Australia, United States
The ApneaLink Air is a compact, portable sleep apnea screening device. It is designed to monitor and record respiratory parameters during sleep. The device is intended to assist healthcare professionals in the diagnosis and management of sleep-related breathing disorders.
Sourced in Japan
The Flexible Videoendoscope is a medical device designed for visual examination of internal body structures. It features a flexible insertion tube that can navigate through complex anatomy, allowing for minimally invasive procedures. The device is equipped with a high-resolution camera and lighting system to provide detailed images of the observed areas.
Sourced in United States, United Kingdom, Japan, Austria, Germany, Denmark, Czechia, Belgium, Sweden, New Zealand, Spain
SPSS version 25 is a statistical software package developed by IBM. It is designed to analyze and manage data, providing users with a wide range of statistical analysis tools and techniques. The software is widely used in various fields, including academia, research, and business, for data processing, analysis, and reporting purposes.
Sourced in United States, Japan, United Kingdom, Germany, Austria, Canada, Belgium, Spain
SPSS version 26 is a statistical software package developed by IBM. It is designed to perform advanced statistical analysis, data management, and data visualization tasks. The software provides a wide range of analytical tools and techniques to help users understand and draw insights from their data.

More about "Excessive Daytime Sleepiness"

Excessive Daytime Sleepiness (EDS) is a common sleep disorder characterized by persistent drowsiness and an inability to stay awake during the day, even after adequate nighttime sleep.
This condition can be caused by a variety of underlying medical issues, such as sleep apnea, narcolepsy, or chronic fatigue syndrome.
Researchers studying EDS can utilize AI-powered research protocols from PubCompare.ai to improve the reproducibility and accuracy of their studies.
This platform allows researchers to easily locate and compare protocols from literature, preprints, and patents to find the best solutions for their research needs.
Experence the power of AI-driven comparisons and discover new insights into this complex sleep disorder.
EDS is also known as hypersomnolence, somnolence, and hypersomnia.
It can have a significant impact on an individual's quality of life, affecting their ability to work, socialize, and perform daily activities.
Researchers may use tools like Alice 6, Alice 4 or 5, Radical-7, Stata 14, Stata version 14, SPSS for Windows version 22.0, ApneaLink Air, Flexible videoendoscope, SPSS version 25, or SPSS version 26 to study and diagnose EDS.
By leveraging the insights gained from PubCompare.ai's AI-powered research protocols, researchers can enhance the reproducibility and accuracy of their studies on Excessive Daytime Sleepiness, leading to a better understanding of this complex sleep disorder and improved treatment options for those affected.